A higher possibility of finding viruses that cause Covid-19 was linked to patients who had taken the antiviral drugs.

Onconova Therapeutics Inc ( (TRAW) ) has released its Q3 earnings. Here is a breakdown of the information Onconova Therapeutics Inc presented ...

While COVID antiviral pills Paxlovid and Molnupiravir have been available for several months, many people have difficulty getting a doctor's prescription during the five-day window. "Individuals ...

Business which accounts for close to one-third of group sales also took in €437m in dividends from subsidiaries dotted ...

Over the last few years, the SARS-CoV-2 virus, responsible for COVID-19, has undergone significant changes, evolving from the ...

SHELTON, CT / ACCESSWIRE / November 15, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that it has filed its Quarterly Report on Form 10-Q for the quarter ending September 30 ...

The company records direct sales and alliance revenues from its partner, BioNTech BNTX, for the COVID-19 vaccine, Comirnaty, and product revenues from its oral antiviral pill for COVID ...

The novel coronavirus SARS-CoV-2 has an enzyme that ... The Kobe University researcher explains: "We may be able to develop new antiviral drugs if we can inhibit the function of the viral enzyme ...

Pfizer reported third-quarter revenue and adjusted profit that blew past expectations. The company hiked its full-year ...

BOTHELL, Wash., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) reports financial results for the three and nine months ended September 30, 2024, ...

NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage global leader in broad-spectrum antiviral nanomedicines, today announces that Anil R. Diwan, Ph.D., the Company’s President ...